https://gvhdhub.com/medical-information/the-rockstar-study-kd025-213-what-patients-with-chronic-gvhd-benefit-most-from-belumosudil
The ROCKstar study (KD025-213): What patients with chronic GvHD benefit most from belumosudil?
During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the GvHD Hub spoke to Steven Z. Pavletic, National Cancer Institute,...